Cosmo Pharmaceuticals NV banner

Intrinsic Value

The intrinsic value of Cosmo Pharmaceuticals NV (CMHC) under the Base Case is 54.3 CHF per share. Compared with the current market price of 53.5 CHF, the stock appears Undervalued by 1% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

CMHC Intrinsic Value
CHf54.3
Undervaluation 1%
Intrinsic Value
Price CHf53.5

We don’t have enough historical valuation data to make this comparison.

Alert me when CMHC is below its intrinsic value
Today CHf43.44 · 18.8% below the current price
Alternatives to CMHC

Fundamental Analysis

What Cosmo Pharmaceuticals Does

Pharmaceuticals Health Care

Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.

Headquarters
Ireland IE
Employees
325
IPO date
May 18, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue CMHC Research

Decided on Cosmo Pharmaceuticals? Get an email when CMHC reaches the price you’d buy at. Free with an account.

Other Cosmo Pharmaceuticals listings

What is the Intrinsic Value of one CMHC stock?

The intrinsic value for Cosmo Pharmaceuticals NV (CMHC) under the Base Case is 54.3 CHF.

Is CMHC stock undervalued or overvalued?

Compared with the current market price of 53.5 CHF, the stock appears Undervalued by 1% .

How reliable are our estimates? See how past valuations played out
Back to Top